Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza control

Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza control

Bibliographic Details
Main Authors:	B. M. Van Maanen, P. T. de Boer, F. C. K. Dolk, A. W. Friedrich, J. C. Wilschut, R. Pitman, M. J. Postma
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-01-01
Series:	Expert Review of Vaccines
Subjects:	cost-effectiveness analysis dynamic modelling seasonal influenza vaccination
Online Access:	http://dx.doi.org/10.1080/14760584.2016.1221347

Similar Items

Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
by: Anita J. Brogan, et al.
Published: (2017-03-01)

Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory Confirmed Influenza in 2014-2015 Season in Turkey: A Test-Negative Case Control Study
by: Can Hüseyin Hekimoğlu1, et al.
Published: (2018-02-01)

Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population
by: Stefano Capri, et al.
Published: (2018-06-01)

Effectiveness of trivalent inactivated influenza vaccines in children during 2017–2018 season in Korea: Comparison of test-negative analysis by rapid and RT-PCR influenza tests
by: Young Joo Sohn, et al.
Published: (2020-10-01)

Cost-Effectiveness of Vaccination of Older Adults with an MF59<sup>®</sup>-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden
by: Jorge Jacob, et al.
Published: (2023-03-01)

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
by: Dominic Thorrington, et al.
Published: (2017-09-01)

Seasonal influenza vaccines: Variability of immune responses to B lineage viruses
by: Matthew S. Miller, et al.
Published: (2024-12-01)

Seasonality as a driver of pH1N12009 influenza vaccination campaign impact
by: Kirsty J. Bolton, et al.
Published: (2023-12-01)

Seasonal influenza vaccine effectiveness among health-care workers in Prince Sultan Military Medical City, Riyadh, KSA, 2018–2019
by: Abdulaziz A. Al Qahtani, et al.
Published: (2021-01-01)

Global dynamic spatiotemporal pattern of seasonal influenza since 2009 influenza pandemic
by: Zhi-Wei Xu, et al.
Published: (2020-01-01)

Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea
by: Youngji Song, et al.
Published: (2024-12-01)

The Usage of Influenza Vaccine to Prevent Seasonal Influenza during Pandemic COVID-19
by: Yelvi Levani, et al.
Published: (2021-08-01)

Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
by: Qiang Wang, et al.
Published: (2023-10-01)

The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses
by: David Fisman, et al.
Published: (2024-12-01)

Debate on the compositions of influenza B in northern hemisphere seasonal influenza vaccines
by: Guozhong He, et al.
Published: (2019-10-01)

Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review
by: Tanja Fens, et al.
Published: (2021-02-01)

Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
by: Analia Urueña, et al.
Published: (2021-04-01)

Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France
by: Marc Paccalin, et al.
Published: (2024-05-01)

Costs per DALYs Averted of Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccine in Elderly Population in Thailand
by: Jadesada Lertsirimunkong, et al.
Published: (2021-03-01)

Regional characteristics of influenza seasonality patterns in mainland China, 2005-2017: a statistical modeling study
by: Xiaowei Deng, et al.
Published: (2023-03-01)

Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes
by: Pieter T. de Boer, et al.
Published: (2020-01-01)

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

Efforts to Improve the Seasonal Influenza Vaccine
by: Alfred T. Harding, et al.
Published: (2018-03-01)

Influenza season - is there anything to worry about?
by: Maciej Dubaj, et al.
Published: (2021-09-01)

The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
by: Michele A. Kohli, et al.
Published: (2021-11-01)

Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh
by: Md Zakiul Hassan, et al.
Published: (2024-01-01)

Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland
by: Van Hung Nguyen, et al.
Published: (2023-05-01)

Influenza vaccine effectiveness against medically-attended influenza infection in 2023/24 season in Hangzhou, China
by: Hao Lei, et al.
Published: (2025-12-01)

Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
by: Onodera H, et al.
Published: (2017-03-01)

Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with influenza-like-illness: impact of diagnostic testing
by: Sarah Tubiana, et al.
Published: (2020-04-01)

Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina
by: Analía Urueña, et al.
Published: (2022-09-01)

Prescription of Antibiotics Among Patients Receiving Oseltamivir with an Influenza Related Diagnosis Over Three Influenza Seasons
by: Mine Durusu Tanriover, et al.
Published: (2024-12-01)

Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies
by: Anthony T. Newall, et al.
Published: (2010-02-01)

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
by: Stephen I. Pelton, et al.
Published: (2020-08-01)

Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
by: Stefan Scholz, et al.
Published: (2019-08-01)

Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
by: Ian McGovern, et al.
Published: (2024-12-01)

Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion
by: Maarten Postma, et al.
Published: (2023-06-01)

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review
by: Gael Dos Santos, et al.
Published: (2018-08-01)

Trust in the Public Health System and Seasonal-Influenza Vaccination
by: Marian Vasile, et al.
Published: (2024-02-01)

Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
by: Edward W. Thommes, et al.
Published: (2017-04-01)